De Novo device
Rewalk
Argo Medical Technologies, Inc. · Powered Exoskeleton (PHL, Class II) · First FDA decision Jun 26, 2014, newest Jun 26, 2014Mobility impairmentSpinal cord injury and paralysis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
13
Naming "Rewalk"
MAUDE reports
0
Brand "Rewalk", since 2015
PubMed studies
43
Mentioning "Rewalk"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Rewalk
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Rewalk", any status and sponsor, newest update first.
- Examination of the Role of Human Exoskeletons in RehabilitationActive, not recruiting
University of PecsAcademic, hospital or other
NCT07669181 · 50 participants (planned) · Start Dec 1, 2017 · Primary completion Dec 2028
Device: Exoskeleton based gait therapy · For: Spinal Cord Injury
Sites: Pécs, Hungary
Shirley Ryan AbilityLabAcademic, hospital or other
NCT06231511 · 26 participants · Start Jul 30, 2021 · Primary completion Apr 15, 2024
Device: Hip flexion soft exosuit; ReWalk ReStore soft exosuit · For: Stroke; Acute Stroke
Sites: Chicago, Illinois
James J. Peters Veterans Affairs Medical CenterFederal agency
NCT02314221 · 73 participants · Start Feb 2015 · Primary completion Sep 2019
Device: Exoskeletal-assisted walking (ReWalk, Ekso) · For: Spinal Cord Injury; Paraplegia; Tetraplegia
Sites: Baltimore, Maryland; West Orange, New Jersey; The Bronx, New York
10 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Rewalk", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PHL
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Rewalk"[tiab]. The summary above synthesizes these.
- Comparison of the dynamics of exoskeletal-assisted and unassisted locomotion in an FDA-approved lower extremity device: Controlled experiments and development of a subject-specific virtual simulator.
Chandran VD, Nam S, Hexner D, et al. · PLoS One · 2023Research Support, U.S. Gov't, Non-P.H.S.
- Assistive powered exoskeleton for complete spinal cord injury: correlations between walking ability and exoskeleton control.
Guanziroli E, Cazzaniga M, Colombo L, et al. · Eur J Phys Rehabil Med · 2019Observational Study
- Overground robotic training effects on walking and secondary health conditions in individuals with spinal cord injury: systematic review.
Tamburella F, Lorusso M, Tramontano M, et al. · J Neuroeng Rehabil · 2022Research Support, Non-U.S. Gov't, Systematic Review
- Heart rate and oxygen demand of powered exoskeleton-assisted walking in persons with paraplegia.
Asselin P, Knezevic S, Kornfeld S, et al. · J Rehabil Res Dev · 2015Observational Study, Research Support, U.S. Gov't, Non-P.H.S.
- Improvement of quality of life after 2-month exoskeleton training in patients with chronic spinal cord injury.
van Nes IJW, van Dijsseldonk RB, van Herpen FHM, et al. · J Spinal Cord Med · 2024Research Support, Non-U.S. Gov't
- Exoskeletons' design and usefulness evidence according to a systematic review of lower limb exoskeletons used for functional mobility by people with spinal cord injury.
Lajeunesse V, Vincent C, Routhier F, et al. · Disabil Rehabil Assist Technol · 2016Systematic Review
- Team IHMC at the 2020 Cybathlon: a user-centered approach towards personal mobility exoskeletons.
Peterson B, Daniel M, Subra Mani V, et al. · J Neuroeng Rehabil · 2022Research Support, Non-U.S. Gov't
- Perspectives of people with spinal cord injury learning to walk using a powered exoskeleton.
Manns PJ, Hurd C, Yang JF · J Neuroeng Rehabil · 2019Clinical Trial, Research Support, Non-U.S. Gov't
- State-of-the-Art in Robotic Rehabilitation for Spinal Cord Injury Patients: A Literature Review.
Lee SH, Ko MJ, Lee YS, et al. · Korean J Neurotrauma · 2025Review
- Exoskeleton home and community use in people with complete spinal cord injury.
van Dijsseldonk RB, van Nes IJW, Geurts ACH, et al. · Sci Rep · 2020Research Support, Non-U.S. Gov't
- The effect of limited sensory information on exoskeleton performance in people with complete spinal cord injury.
Zwijgers E, Nienhuis B, Rijken H, et al. · IEEE Int Conf Rehabil Robot · 2022
- Retraining walking over ground in a powered exoskeleton after spinal cord injury: a prospective cohort study to examine functional gains and neuroplasticity.
Khan AS, Livingstone DC, Hurd CL, et al. · J Neuroeng Rehabil · 2019Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code PHL.
- Indego(R)Parker-Hannifin Corporation · 510(k) 2018
- Atalante XWandercraft SAS · 510(k) 2025
- ReWalk P6.0Re Walk Robotics , Ltd. · 510(k) 2023
- EksoNREkso Bionics, Inc. · 510(k) 2022
- HAL for Medical Use(Lower Limb type)Cyberdyne, Inc. · 510(k) 2020
- Ekso (version 1.1) and Ekso GT (version 1.2)Ekso Bionics, Inc. · 510(k) 2016
- Trexo TheoTrexo Robotics, Inc. · 510(k) 2026
- EveWandercraft SAS · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.